Two coronavirus vaccines begin the last phase of testing: 30,000-person trials - The Washington Post

The first participants received shots in a 30,000-person trial of an experimental vaccine being developed by biotech company Moderna in partnership with the U.S. government. https://www.washingtonpost.com/health/2020/07/27/moderna-nih-launch-30000-person-trial-coronavirus-vaccine/